Previous 10 | Next 10 |
Gainers: Fluidigm Corporation (NASDAQ: FLDM ) +33% . More news on: Fluidigm Corporation, SCWorx Corp., Anaplan, Inc., Stocks on the move, Read more ...
Tyme Technologies (NASDAQ: TYME ) +29% as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. More news on: Tyme Technologies, Inc., SCWorx Corp., Immunic, Inc., Stocks on the move, , Read more ...
Gainers: Viveve Medical (NASDAQ: VIVE ) +111% . More news on: Viveve Medical, Inc., VivoPower International PLC, Sigma Labs, Inc., Stocks on the move, , Read more ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Volatility watch: Heading into the new week, short interest is on the rise on Royal Bank of Canada (NYSE: RY ) ahead of the bank's earnings report on August 26 and AstraZeneca (NYSE: AZN ) amid COVID-19 developments. Meanwhile, GameStop (NYSE: GME ) is cruising along with an exceedi...
Will These Penny Stocks Remain Below $2.25 In August? As the saying goes, you get what you pay for. But does that apply to penny stocks ? Granted, these stocks under $5 are “cheap” according to most. But these small- and micro-cap stocks can pack a punch. This year it’s ...
Will These 3 Penny Stocks Make New August Highs This Week Penny stocks weathered the storm on Monday as broader markets pulled back. Major tech stocks like Apple, Amazon, Square, Netflix, Twitter, you name it, most slipped in early trading. If you’ve been reading the news recently,...
SALT LAKE CITY , Aug. 6, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the second quarter ended June 30, 2020 and provided a corporate update. ...
Highway Holdings (NASDAQ: HIHO ) +102% . More news on: Highway Holdings Limited, ADT Inc., CymaBay Therapeutics, Inc., Stocks on the move, , Read more ...
SALT LAKE CITY , Aug. 3, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the peer reviewed publication of LPCN 144 Liver Fat Study ("LFS") results, "LPCN 1144 Resolves Non-Alco...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 02:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study PR Newswire Met standard bioequivalence (BE) criteria C max, AUC 0-t , and AUC 0- ∞ C trough criterion was met LPCN 1154 was well tolerat...
Shares of Lipocine Inc. (NASDAQ: LPCN) traded at a new 52-week high today and are currently trading at $8.96. So far today, approximately 78,318 shares have been exchanged, as compared to an average 30-day volume of 32,701 shares. Lipocine Inc., a clinical-stage biopharmaceutical company, foc...